The RIVET RCT: Rifamycin SV MMX improves muscle mass, physical function, and ammonia in cirrhosis and minimal encephalopathy.
Article in Hepatology Communications (February 2024)
The most recent citing publications are shown below. View all 69 publications that cite this research output on Dimensions.
Chronic Hyponatremia and Brain Structure and Function Before and After Treatment
Article in American Journal of Kidney Diseases (January 2024)
Experimental Models of Posterior Reversible Encephalopathy Syndrome: A Review From Pathophysiology to Therapeutic Targets
Article in Stroke (December 2023)